The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in patients with polycythemia vera (PV).
 
Ciro Rinaldi
No Relationships to Disclose
 
Lindsay Rein
Consulting or Advisory Role - Abbvie; Blueprint Medicines; CTI BioPharm/Sobi; Incyte; MorphoSys; Novartis; Sumitomo
Research Funding - Actuate Therapeutics; Blueprint Medicines; Cogent Biosciences; Geron; Incyte; Karyopharm Therapeutics; Merck/Imago; Novartis; PharmaEsssentia; Protagonist Therapeutics; Sumitomo
Travel, Accommodations, Expenses - DAVA Oncology
 
Alice Livings
No Relationships to Disclose
 
Andrew J. Innes
Consulting or Advisory Role - Novartis
Speakers' Bureau - Incyte; Novartis
 
Kristen Pettit
Consulting or Advisory Role - Abbvie; Incyte; Merck; PharmaEssentia; Protagonist Therapeutics; SOBI
Research Funding - Abbvie; Blueprint Medicines; Kura Oncology; Merck; Protagonist Therapeutics; SOBI
 
Paul Yeh
Research Funding - Astellas Pharma (Inst)
 
Stephen R. Larsen
No Relationships to Disclose
 
Anne-Marie Watson
No Relationships to Disclose
 
Michael F. Leahy
No Relationships to Disclose
 
Natalia Curto-Garcia
Consulting or Advisory Role - Medscape
 
Ali Mahdi
No Relationships to Disclose
 
Rebecca Frewin
Honoraria - Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; CTI
Research Funding - GlaxoSmithKline; Incyte
Travel, Accommodations, Expenses - Novartis
 
Haifz Qureshi
Travel, Accommodations, Expenses - Novartis
 
Joseph Shatzel
No Relationships to Disclose
 
Jennifer Vaughn
Consulting or Advisory Role - Cogent Biosciences; Ionis Pharmaceuticals
 
Tsewang Tashi
Consulting or Advisory Role - Blueprint Medicines; Cogent Biosciences; Pharmaessentia
Research Funding - Blueprint Medicines; Cogent Biosciences; Glycomimetics; Italfarmaco; Merck; Pharmaessentia
 
Harshad Amin
Stock and Other Ownership Interests - CGI Therapeutical; GTHX; Karyopharm Therapeutics
 
Uzor Ogbu
Employment - Merck
Stock and Other Ownership Interests - Merck; Roche
 
Burak Gumuscu
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
David M. Ross
Honoraria - Novartis
Consulting or Advisory Role - Avance CRO; Keros Therapeutics; Menarini; Novartis; Takeda
Research Funding - GlaxoSmithKline; Incyte; Keros Therapeutics; MorphoSys; MSD; Novartis; Protagonist Therapeutics; Sumitomo